2014
NOS3 894G > T Polymorphism is Associated With Progression of Kidney Disease and Cardiovascular Morbidity in Type 2 Diabetic Patients: NOS3 as a Modifier Gene for Diabetic Nephropathy?
KURICOVÁ, Katarína; Veronika DVOŘÁKOVÁ; Lukáš PÁCAL; Vendula BARTÁKOVÁ; Lucie BROŽOVÁ et al.Základní údaje
Originální název
NOS3 894G > T Polymorphism is Associated With Progression of Kidney Disease and Cardiovascular Morbidity in Type 2 Diabetic Patients: NOS3 as a Modifier Gene for Diabetic Nephropathy?
Autoři
KURICOVÁ, Katarína; Veronika DVOŘÁKOVÁ; Lukáš PÁCAL; Vendula BARTÁKOVÁ ORCID; Lucie BROŽOVÁ; Jiří JARKOVSKÝ ORCID a Kateřina KAŇKOVÁ
Vydání
Kidney and Blood Pressure Research, Karger, 2014, 1420-4096
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30105 Physiology
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.123
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/14:00080127
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Diabetic nephropathy; Nitric oxide synthase; Polymorphism; Cardiovascular morbidity
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 24. 4. 2015 14:29, Soňa Böhmová
Anotace
V originále
Background/Aims: We have previously associated SNP 894G>T in the NOS3 gene with diabetic nephropathy (DN) using multi-locus analysis. Variant 894G>T has been widely studied as a DN susceptibility factor with contradictory results. In the present study we genotyped 894G>T in the cohort of prospectively followed type 2 diabetics with the aim to investigate its possible role in the progression of DN and development of morbidity and mortality associated with diabetes. Methods: 311 subjects with defined stage of DN were enrolled in the study and followed up for a median of 38 months. We considered three end-points: progression of DN, major cardiovascular event and all-cause mortality. Results: Considering baseline GFR, age at enrolment and diabetes duration as confounders, Cox regression analysis identified 894GTgenotype as a risk factor for DN progression (HR = 1.843 [95% CI 1.088 – 3.119], P = 0.023) and 894TT genotype as a risk factor for major cardiovascular event (HR = 2.515 [95% CI 1.060 – 5.965], P = 0.036). Conclusion: We ascertained the significant effect of the NOS3 894G>T variant on DN progression and occurrence of major cardiovascular event in T2DM subjects. Based on these results NOS3 can be considered a modifier gene for DN.
Návaznosti
| NT11405, projekt VaV |
|